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INTRODUCTION
Bariatric surgery, such as Roux-en-Y gastric bypass (RYGB), is
currently the most effective treatment for obesity and often results
in type 2 diabetes resolution and possibly type 2 diabetes prevention
(Buchwald et al., 2004; Cummings et al., 2010c; Schauer et al., 2012;
Sjöström et al., 2004). However, the mechanisms (beyond body
weight reduction) responsible for these effects remain undefined.
Although gastric restriction and malabsorption probably contribute
to maintenance of long-term weight loss, there is increased interest
in the role of endocrine and metabolite changes in the effects of
bariatric surgery to induce weight loss and prevent diabetes onset
(Scott and Batterham, 2011; Thaler and Cummings, 2009). In
particular, post-operative elevations in circulating bile acids have
become an increasingly cited mechanism for the metabolic benefits
of bariatric surgeries, such as RYGB and vertical sleeve gastrectomy
(Cummings et al., 2012; Patti et al., 2009; Thaler and Cummings,
2009). RYGB produces several post-operative alterations in normal
GI anatomy and function, such as reduction in gastric volume,
bypass of the proximal small intestine and increased flux of
incompletely absorbed nutrients and bile into the distal small
intestine. By contrast, ileal interposition (IT) surgery only involves
transposition of a segment of distal small intestine into the proximal
jejunum. Thus, the only major change produced by this surgery is
increased flux of incompletely absorbed nutrients and bile to the
distal small intestine (Strader, 2006). By investigating the effects of
only one of the anatomical alterations produced by RYGB in
isolation, we can better assess mechanisms by which this
component of bariatric surgery improves glucose metabolism.
Plasma bile acids are elevated after bariatric surgeries such as
RYGB and IT surgery in rodents and clinical studies in humans
and have been suggested to have a role in producing the metabolic
benefits observed after these types of bariatric surgery (Kohli et
al., 2010; Nakatani et al., 2009; Patti et al., 2009). However, the
mechanisms by which post-operative increases in circulating bile
acid concentrations contribute to the metabolic benefits of bariatric
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SUMMARY
Post-operative increases in circulating bile acids have been suggested to contribute to the metabolic benefits of bariatric surgery; however, their
mechanistic contributions remain undefined. We have previously reported that ileal interposition (IT) surgery delays the onset of type 2 diabetes
in UCD-T2DM rats and increases circulating bile acids, independently of effects on energy intake or body weight. Therefore, we investigated potential
mechanisms by which post-operative increases in circulating bile acids improve glucose homeostasis after IT surgery. IT, sham or no surgery was
performed on 2-month-old weight-matched male UCD-T2DM rats. Animals underwent an oral fat tolerance test (OFTT) and serial oral glucose tolerance
tests (OGTT). Tissues were collected at 1.5 and 4.5 months after surgery. Cell culture models were used to investigate interactions between bile acids
and ER stress. IT-operated animals exhibited marked improvements in glucose and lipid metabolism, with concurrent increases in postprandial
glucagon-like peptide-1 (GLP-1) secretion during the OFTT and OGTTs, independently of food intake and body weight. Measurement of circulating
bile acid profiles revealed increases in circulating total bile acids in IT-operated animals, with a preferential increase in circulating cholic acid
concentrations. Gut microbial populations were assessed as potential contributors to the increases in circulating bile acid concentrations, which
revealed proportional increases in Gammaproteobacteria in IT-operated animals. Furthermore, IT surgery decreased all three sub-arms of ER stress
signaling in liver, adipose and pancreas tissues. Amelioration of ER stress coincided with improved insulin signaling and preservation of β-cell mass
in IT-operated animals. Incubation of hepatocyte, adipocyte and β-cell lines with cholic acid decreased ER stress. These results suggest that post-
operative increases in circulating cholic acid concentration contribute to improvements in glucose homeostasis after IT surgery by ameliorating ER
stress.
Bile-acid-mediated decrease in endoplasmic reticulum
stress: a potential contributor to the metabolic benefits
of ileal interposition surgery in UCD-T2DM rats
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Kimber L. Stanhope1,2, Cecilia Giulivi1,4, Frederik Hansen5, Jacob Jelsing5, Niels Vrang5, Mark Kowala6, Michael L. Chouinard6,
Fawaz G. Haj2 and Peter J. Havel1,2
RESEARCH ARTICLE
D
ise
as
e 
M
od
el
s &
 M
ec
ha
ni
sm
s  
    
   D
M
M
surgery have not been demonstrated. Potential mechanisms by
which increases in circulating bile acid concentrations could
improve glucose homeostasis include signaling through the
membrane-bound G-protein-coupled receptor, TGR5, and the
nuclear receptor, FXR. Bile acid signaling through TGR5 receptors
on brown adipose tissue increases energy expenditure (Watanabe
et al., 2006). Furthermore, bile acid signaling through hepatic FXR
decreases hepatic gluconeogenesis and lipogenesis (Thomas et al.,
2008).
Another potential mechanism by which post-operative increases
in circulating bile acids could improve glucose homeostasis is
through amelioration of endoplasmic reticulum (ER) stress in
peripheral insulin-sensitive tissues. ER stress has been shown to play
an integral role in the development of insulin resistance and diabetes
(Ozcan et al., 2004) and administration of tauroursodeoxycholic acid
(TUDCA) has been shown to decrease ER stress and improve insulin
sensitivity in a mouse model of obesity (Ozcan et al., 2006).
However, the effect of other sub-types of bile acids on ER stress has
not been previously investigated. Therefore, we hypothesized that
bile acids, other than TUDCA, that are increased after bariatric
surgery might act to decrease ER stress. ER stress occurs when the
folding capacity of the ER is exceeded and unfolded or misfolded
proteins accumulate, leading to the unfolded protein response
(UPR). The UPR is triggered by transmembrane sensors that detect
unfolded proteins in the ER. These proteins are: PKR-like ER kinase
(PERK), inositol-requiring enzyme 1α (IRE1α) and activating
transcription factor 6 (ATF6) (Hotamisligil, 2010). Activation of
PERK results in phosphorylation and inactivation of eukaryotic
translation inhibition factor 2α (eIF2α), which inhibits protein
synthesis. The UPR also upregulates the synthesis of chaperone
proteins, such as binding immunoglobulin protein (BiP), to assist
with the increased misfolded protein load (Ron and Walter, 2007).
One previous study reported attenuation of ER stress in liver and
adipose tissue after weight loss induced by RYGB in humans
(Gregor et al., 2009). However, the effect of any type of bariatric
surgery, independently of body weight loss, on markers of ER stress
has not been previously investigated.
Because the mechanisms by which post-operative increases in
circulating bile acids contribute to the improvements in glucose
homeostasis after bariatric surgery are undefined, the primary goal
of this study was to investigate one potential contributing
mechanism. In particular, we focused on the interaction between
post-operative increases in circulating bile acids and ER stress
signaling. Our previous study of IT surgery in pre-diabetic UCD-
T2DM rats demonstrated that IT surgery delays diabetes onset by
4 months (equivalent to ~10 years in a human life-span) and
increases total circulating bile acids, independently of changes in
food intake or body weight (Cummings et al., 2010c). The UCD-
T2DM rat model of type 2 diabetes develops adult-onset polygenic
obesity, insulin resistance and marked hyperglycemia, without a
defect in leptin signaling (Cummings et al., 2008). Therefore, use
of the UCD-T2DM rat model in combination with the IT surgical
model is ideal for study of mechanisms by which post-operative
increases in circulating bile acid concentrations improve glucose
and lipid metabolism in type 2 diabetes.
RESULTS
IT surgery increases diabetes-free days and energy expenditure
Male UCD-T2DM rats underwent surgery at 2 months of age and
were studied for either 1.5 (short-term study) or 4.5 months (long-
term study). As expected from our previous study (Cummings et
al., 2010c), in the long-term study, the average number of diabetes-
free days was greater in the IT-operated group (191±5 days) than
in control and sham-operated animals (control166±11 days,
sham172±7 days; P<0.05). IT surgery also decreased diabetes
incidence in the long-term study such that incidence was 38% in
IT-operated animals and 62% and 69% in control and sham-
operated animals, respectively. No animals in the short-term study
developed diabetes. Correspondingly, glycosylated hemoglobin
(HbA1c), fasting plasma glucose, insulin, homeostatic model
assessment of insulin resistance (HOMA-IR) and triglyceride (TG)
concentrations were lower and glucagon-like peptide-1 (GLP-1) was
higher in IT-operated animals than in controls (P<0.05)
(supplementary material Table S1). Food intake and body weight
did not differ significantly between groups (Fig. 1A,B).
Energy expenditure was ~4% higher in IT-operated animals
compared with control and sham-operated animals during the dark
cycle at 1.5 months after surgery (P<0.05) (Fig. 1C,D). However,
total locomotor activity did not differ between groups (Fig. 1E,F).
Thus, the increase in energy expenditure appears to be mediated
by increased thermogenesis, rather than by increased physical
activity.
IT surgery improves glucose metabolism and preserves β-cell
mass
We previously reported that IT surgery improved glucose
tolerance, glucose-stimulated insulin secretion (GSIS) and
dmm.biologists.org444
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TRANSLATIONAL IMPACT
Clinical issue
The global prevalence of obesity and type 2 diabetes is increasing at an
alarming rate. Bariatric surgery is the most effective treatment for obesity and
type 2 diabetes, but the mechanisms responsible are incompletely
understood. Circulating bile acid concentrations are elevated after several
types of bariatric surgery, and it has been suggested that the increase in bile
acids contributes to the metabolic benefits. However, the mechanistic
contributions of increased circulating bile acids to the beneficial effects of
bariatric surgery remain undefined
Results
In this study, the authors addressed this issue in a novel rat model of type 2
diabetes. After ileal interposition (IT) surgery, improvements in glucose
tolerance and β-cell mass coincided with the amelioration of ER stress
signaling in liver, adipose and pancreas tissues in this model, independently of
body weight changes. Moreover, non-conjugated cholic acid concentrations
were preferentially increased after IT surgery in pre-diabetic rats. Finally,
incubation of cultured hepatocytes, white adipocytes and β-cells with cholic
acid protected all of these cells against the development of ER stress.
Implications and future directions
These results suggest that increases in circulating cholic acid concentrations
after IT surgery contribute to improvements in glucose metabolism by
decreasing ER stress. This effect of bariatric surgery on ER stress represents a
previously unrecognized mechanism by which increases in circulating bile
acids after bariatric surgery improve glucose homeostasis. These results
advance our understanding of the metabolic benefits of bariatric surgery and
suggest that targeting bile acid metabolism could be useful in both the
treatment and prevention of type 2 diabetes.
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nutrient-stimulated GLP-1 secretion at 1 month after surgery
(Cummings et al., 2010c). In order to assess the preservation of
these improvements over time, serial oral glucose tolerance tests
(OGTTs) were performed at 1, 3 and 4 months after surgery. An
oral fat tolerance test (OFTT) was performed at 2 months after
surgery. Glucose excursions during all three OGTTs were lower
in IT-operated animals compared with control and sham-operated
animals (P<0.01), except at 3 months where glucose excursions
in IT-operated animals were only significantly lower compared
with non-operated control animals (P<0.05) (Fig. 2A-C). During
the 1 month OGTT, insulin values were significantly lower in IT-
operated animals compared with control and sham-operated
animals at multiple time points, suggesting an improvement in
insulin sensitivity (P<0.01) (Fig. 2D). The increase in plasma
insulin concentrations from fasting to peak values was about
twofold greater in IT-operated animals than in control and sham-
operated animals during all 3 OGTTs (P<0.01) (Fig. 2D-F),
demonstrating an improvement in GSIS after IT surgery
(supplementary material Table S2).
Total GLP-1 secretion was fourfold greater in IT-operated
animals at 1 and 4 months after surgery compared with control
and sham-operated animals (P<0.001) (Fig. 2G-H). Furthermore,
the GLP-1 area under the curve (AUC) in IT-operated animals
at 4 months after surgery was 39% greater compared with the
GLP-1 AUC at 1 month after surgery (P<0.05). Thus, nutrient-
stimulated GLP-1 secretion appears to increase over time after
IT surgery in UCD-T2DM rats. Similar to previous work,
nutrient-stimulated glucose-dependent insulinotropic
polypeptide secretion did not differ between groups during the
OGTT at 3 months after surgery (Fig. 2I), whereas nutrient-
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Fig. 1. IT surgery does not affect food intake or body weight, but increases energy expenditure. Energy intake (A), body weight (B), energy expenditure (C),
energy expenditure AUC (D), total physical activity (E) and sum of total physical activity (F) in control (n16), sham (n16) and IT-operated (n16) animals. *P<0.05
compared with control and sham by Student’s t-test.
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stimulated peptide YY secretion was markedly elevated in IT-
operated animals during the OFTT at 2 months after surgery
(P<0.05) (Fig. 2J) (Cummings et al., 2010c).
To investigate the molecular basis for enhanced insulin sensitivity
in IT-operated animals, we analyzed downstream components of
insulin signaling pathways in peripheral tissues of fasted control,
sham and IT-operated animals at 1.5 and 4.5 months after surgery.
Protein kinase B (Akt) (Ser473) and mitogen-activated protein
kinase (MAPK) (Thr202/Tyr204) phosphorylation, normalized to
their protein expression, were two- to threefold higher in liver,
skeletal muscle, mesenteric adipose and pancreas in IT-operated
animals compared with control animals (P<0.05) (Fig. 3).
Furthermore, c-Jun N-terminal kinase (JNK) (Thr183/Tyr185)
phosphorylation was reduced in liver, skeletal muscle, mesenteric
adipose and pancreas tissues in IT-operated animals compared with
controls at 4.5 months after surgery (P<0.05) (Fig. 3). These results
are consistent with an improvement in insulin signaling after IT
surgery.
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Fig. 2. IT surgery improves glucose tolerance, islet function and nutrient-stimulated GLP-1 secretion. (A-C)Circulating glucose concentrations during
OGTTs at 1 (A), 3 (B) and 4 (C) months after surgery. (D-F)Circulating insulin concentrations during OGTTs at 1 (D), 3 (E) and 4 (F) months after surgery.
(G,H)Circulating GLP-1 concentrations during OGTTs at 1 (G) and 4 (H) months after surgery. (I)Circulating GIP concentrations during the OGTT at 3 months after
surgery. (J,K)Circulating PYY (J) and TG concentrations (K) during the OFTT at 2 months after surgery. During the first month OGTT, n28 per group. During the
third and fourth month OGTTs and second month OFTT, n 16 per group. **P<0.01, ***P<0.001 for IT compared with control and sham by Student’s t-test of the
AUC. *P<0.05 for IT compared with control by Student’s t-test of the AUC. ++P<0.01, +++P<0.001 for IT compared with control and sham by Student’s t-test of the
percentage change from fasting to peak insulin values.
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Based on the observed improvement in GSIS, we hypothesized
that there might be a related preservation of pancreatic β-cell mass
in IT-operated animals. β-cell mass was quantified at 1.5 and 4.5
months after surgery in order to assess temporal changes. At 1.5
months after surgery, islets appeared smaller and β-cell mass was
lower in IT-operated animals compared with control and sham-
operated animals (P<0.05) (Fig. 4A-C,G). At 4.5 months after
surgery, islets in IT-operated animals appeared to have better
preservation of islet architecture, and β-cell mass was higher in IT-
operated animals compared with sham-operated animals (P<0.05)
(Fig. 4D-G).
IT surgery improves lipid metabolism
During the OFTT at 2 months after surgery, TG excursions were
65% lower in IT-operated animals compared with control and
sham-operated animals, suggesting an improvement in lipid
clearance (P<0.001) (Fig. 2K). Furthermore, skeletal muscle and
hepatic ectopic lipid deposition were decreased in IT-operated
animals compared with control animals at 1.5 months after surgery
(supplementary material Table S1). However, at 4.5 months after
surgery this difference was no longer present (supplementary
material Table S1). This was probably due to the development of
diabetes in control and sham-operated animals and subsequent
utilization of body lipids for energy at 4.5 months, resulting in lower
ectopic TG deposition. Indeed, we have previously reported that
the progression of diabetes in the UCD-T2DM rat is associated
with decreases in adiposity and ectopic lipid deposition (Cummings
et al., 2008). Similarly, total white adipose tissue mass was
significantly reduced in IT-operated animals at 1.5 months after
surgery, but not at 4.5 months after surgery (supplementary
material Table S3).
IT surgery increases total circulating bile acids
We and others have reported that circulating bile acid
concentrations are increased after IT surgery (Cummings et al.,
2010c; Kohli et al., 2010). In order to assess these changes in detail,
we determined fasting plasma bile acid profiles at 2 months after
surgery (Fig. 5A-C). Total fasting plasma bile acid concentrations
and all major bile acid sub-types were increased in IT-operated
animals compared with control and sham-operated animals
(P<0.001) (Fig. 5D). However, when expressed as a percentage of
total bile acids, bile acid pools in IT-operated animals had
proportionally greater cholic acid and proportionally lower
muricholates and deoxycholates (P<0.05) (Fig. 5A-C). Similarly,
absolute concentrations of both primary and secondary bile acid
concentrations were elevated in IT-operated animals (P<0.001) (Fig.
5E); however, only primary bile acids were significantly increased
as a proportion of the total bile acid pool in IT-operated animals
compared with controls (P<0.05). Circulating non-conjugated bile
acid and non-conjugated cholic acid concentrations were increased
in IT-operated animals compared with controls when expressed as
an absolute value or as a percentage of the total bile acid pool
(P<0.01) (Fig. 5A-C,E). Thus, there was a preferential increase in
circulating non-conjugated cholic acid in IT-operated animals.
However, hepatic total bile acid content and hepatic total cholic
acid content did not differ significantly between groups (Fig. 5F),
suggesting that the increase in circulating total bile acids in IT-
operated animals was unlikely to be due to increased hepatic bile
Disease Models & Mechanisms 447
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Fig. 3. IT surgery improves insulin signaling in liver, skeletal muscle, mesenteric adipose and pancreas. (A)Representative immunoblots for pAkt (Ser473),
total Akt, pMAPK(Thr202/Tyr204), total MAPK, pJNK(Thr183/Tyr185) and total JNK in liver, adipose, skeletal muscle and pancreas at 1.5 and 4.5 months after
surgery. (B-E)Results were quantified in densitromic units and expressed relative to the total protein of interest in liver (B), skeletal muscle (C), mesenteric
adipose (D) and pancreas (E). *P<0.05, **P<0.01, ***P<0.001 for IT compared with control and sham by Student’s t-test; n12 per group at 1.5 months and n16
per group at 4.5 months.
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acid production. Cecal total bile acid concentrations were
significantly lower in IT-operated animals compared with sham-
operated animals (P<0.05); however, this difference did not reach
significance when compared with the control group (Fig. 5G). This
intestinal content sample was collected after an overnight fast,
which might have blunted the difference in intestinal bile acid
content between the IT-operated and control groups.
Fasting plasma glycine-conjugated bile acid concentrations were
elevated in IT-operated animals compared with controls when
expressed as either an absolute value or as a percentage of the total
bile acid pool (P<0.001) (Fig. 5H,I). Furthermore, glycine-
conjugated bile acids were also increased in the liver of IT-operated
animals compared with controls as both an absolute value and as
a percentage of the total hepatic bile acid pool (P<0.001) (Fig. 5J).
These data coincide with previously published data on bile acid
profiles after IT surgery (Kohli et al., 2010) and suggest a shift in
hepatic bile acid metabolism, possibly due a change in taurine
availability.
Elevations in circulating bile acids might improve glucose and
lipid metabolism via activation of FXR. Therefore, the expression
of hepatic genes involved in this pathway were investigated by real-
time PCR (rtPCR). Although the gene expression of hepatic sterol
regulatory element-binding protein 1c (SREBP1c) and cholesterol
7 α-hydrolase (CYP7a1) tended to be decreased in IT-operated
animals; sodium/bile acid co-transporter (SLC10a1), CYP7a1,
sterol 12 α-hydrolase (CYP8b1), liver receptor homolog 1 (LRH-
1), small heterodimeric partner (SHP), bile acyl-CoA synthetase
(SLC27a5) and SREBPc1 did not differ between groups, indicating
that the FXR signaling pathway was not significantly engaged
following IT surgery (Fig. 5K).
Because the gut microbiome is known to play an important role
in bile acid metabolism, gut microbial populations were assessed
from intestinal content samples collected from the cecum by
pyrosequencing at 4.5 months after surgery. Specifically,
proportions of bacterial phyla did not differ between groups (Fig.
6A). However, similar to previous results reported in humans after
RYGB, Gammaproteobacteriawere elevated twofold in IT-operated
animals compared with controls (P<0.05) (Fig. 6B) (Zhang et al.,
2009). At the genus level, Escherichia was elevated in IT-operated
animals (P<0.05) (Fig. 6C).
IT surgery decreases ER stress
Based on the marked improvements of glucose homeostasis and
insulin signaling, we hypothesized that IT surgery might
contribute to these effects through a decrease in ER stress
signaling. Therefore, we assessed activation of the three sub-arms
of ER stress signaling. Immunoblot analysis of liver, adipose and
pancreas lysates revealed that phosphorylation of PERK (Thr980),
dmm.biologists.org448
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Fig. 4. IT surgery preserves β-cell mass. (A-F)Representative images of pancreas sections immunostained for insulin from pre-diabetic control (A), sham (B) and
IT-operated animals (C) at 1.5 months after surgery and control (D), sham (E) and IT-operated animals (F) at 4.5 months after surgery. (G)β-cell quantification in a
subset of samples from control (n6), sham (n 6) and IT-operated animals (n6) at 1.5 months after surgery and control (n6), sham (n7) and IT-operated
animals (n8) at 4.5 months after surgery. *P<0.05, **P<0.01 for IT compared with control and sham by Student’s t-test.
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eIF2α (Ser51) and IRE1α (Ser724) and expression of X-box
binding protein-1 (sXBP1), ATF6 and BiP protein were reduced
in IT-operated animals compared with sham and control groups
at both 1.5 and 4.5 months after surgery (P<0.05) (Fig. 7A-B,D-
E), except that hepatic BiP expression did not differ between
groups at 1.5 months. However, markers of ER stress in skeletal
muscle did not differ between groups at 1.5 months after surgery,
but were two- to threefold lower in IT-operated animals at 4.5
months after surgery (P<0.05) (Fig. 7C).
One of the major mechanisms by which ER stress is proposed
to contribute to the development of insulin resistance is through
the promotion of inflammation (Hotamisligil, 2010). Therefore,
markers of inflammation, tumor necrosis factor-α (TNF-α) and
monocyte chemotactic protein-1 (MCP-1), were measured. At 1.5
months after surgery only TNF-α was reduced in adipose tissue
from IT-operated animals (P<0.05). However, TNF-α and MCP-1
were markedly reduced in liver, muscle and mesenteric adipose
tissue in IT-operated animals compared with controls animals at
4.5 months after surgery (P<0.05) (supplementary material Fig. S1).
This difference persisted without inclusion of diabetic animals in
the analysis, indicating that the effect of IT surgery in reducing
markers of inflammation was independent of diabetes.
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Fig. 5. IT surgery preferentially increases nonconjugated primary bile acids. (A-C)Fasting plasma bile acid profiles in control (A), sham (B) and IT-operated
animals (C) at 2 months after surgery. (D)Fasting plasma bile acid concentrations. (E)Fasting plasma non-conjugated bile acid, non-conjugated cholic acid,
primary bile acid and secondary bile acid concentrations. (F)Hepatic bile acid profiles. (G)Bile acid profiles in cecal contents. (H)Fasting plasma glycine-
conjugated bile acid concentrations. (I)Fasting plasma glycine-conjugated bile acid concentrations expressed as a percentage of conjugated bile acids.
(J)Hepatic glycine-conjugated bile acid concentrations expressed as an absolute value and as a percentage of the total hepatic bile acid pool. (K)Hepatic mRNA
expression of genes involved in bile acid metabolism and the FXR pathway relative to ARBP. All plasma values were measured at 2 months after surgery. Liver and
cecal contents values were measured at 4.5 months after surgery; n16 per group. *P<0.05, **P<0.01, ***P<0.001 for IT compared with control and sham, +P<0.05
compared with sham by Student’s t-test. C, cholate; CDC, chenodeoxycholate; DCA, deoxycholate; GC, glycocholate; GCDC, glycochenodeoxycholate; GDC,
glycodeoxycholate; GHDC, glycohyodeoxycholate; HDC, hyodeoxycholate; T-a-MC, tauro-α-muricholate; T-b-MC, tauro-β-muricholate; TC, taurocholate; TCDC,
taurochenodeoxycholate; TDC, taurodeoxycholate; THDC, taurohyodeoxycholate; TTHC, taurotetrahyodeoxycholate; TUDC, tauroursodeoxycholate.
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Cholic acid decreases ER stress in liver, adipocyte and β-cell
culture
Based on previous work demonstrating that TUDCA decreases ER
stress and improves insulin sensitivity (Ozcan et al., 2006), we
hypothesized that other bile acids might also ameliorate ER stress.
Thus, we tested the effect of cholic acid, the bile acid that was
increased by the greatest magnitude after IT surgery, to attenuate
ER stress in cultured hepatocytes, adipocytes and β-cells. Cells were
incubated for 24 hours in the presence or absence of cholic acid
(100 μM). ER stress was induced by treatment with thapsigargin
(2 μM) for 2 hours. Thapsigargin treatment resulted in significant
increases in markers of the PERK, IRE1α and ATF6 pathways of
ER stress in all cell types. Pretreatment of hepatocytes with cholic
acid resulted in normalization of markers of the IRE1α and ATF6
pathways of ER stress to control levels (Fig. 8A,B). Pretreatment
of adipocytes with cholic acid resulted in reductions of markers of
the PERK and IRE1α pathways of ER stress (P<0.05) (Fig. 8A,C).
Pretreatment of β-cells with cholic acid resulted in reductions of
the PERK- and ATF6-mediated pathways of ER stress and
reductions of IRE1α (Ser724) phosphorylation but not sXBP1
expression (Fig. 8A,D). In contrast to IT-operated animals,
pretreatment of hepatocytes with cholic acid did not affect
activation of the PERK pathway of ER stress, and pretreatment of
adipocytes with cholic acid did not affect activation of the ATF6
pathway of ER stress. Overall, these results support our hypothesis
that cholic acid can improve glucose homeostasis by attenuating
ER stress.
DISCUSSION
In this study we demonstrate that IT surgery in pre-diabetic UCD-
T2DM rats results in marked improvements in glucose and lipid
metabolism, with concurrent increases in circulating bile acids. We
also found significant decreases in ER stress signaling in peripheral
tissues of IT-operated animals, which probably contributed to the
improvements in insulin sensitivity and preservation of β-cell mass.
Furthermore, we demonstrate that incubation with cholic acid
protects cells from the development of ER stress in hepatocyte,
adipocyte and β-cell culture, suggesting that increases in circulating
bile acid concentrations might contribute to attenuation of ER
stress. Thus, we have identified a potential pathway by which post-
operative increases in circulating bile acids might improve
metabolic homeostasis after bariatric surgery.
Similar to previous studies, we found that fasting plasma total
bile acid concentrations were markedly elevated in IT-operated
animals and that IT surgery produced a preferential increase in
circulating non-conjugated cholic acid concentrations (Cummings
et al., 2010c; Kohli et al., 2010). However, hepatic total bile acid
content and hepatic cholic acid content did not differ between
groups. These data are consistent with previous reports (Kohli et
al., 2010) and support the hypothesis that IT surgery results in an
increase in circulating bile acids by increasing reabsorption of bile
acids in the transposed ileal segment. However, the gut microbiome
has received increasing attention for its role in modulating bile acid
metabolism and thus post-operative changes in gut microbial
populations might also contribute to post-operative changes in bile
acid absorption (Swann et al., 2011). Surprisingly, changes in gut
microbial populations after IT surgery were small in comparison
to the phyla-level alterations in gut microbiome composition
reported after RYGB. Studies in humans and rodents report
proportional decreases in Firmicutes after RYGB (Li et al., 2011;
Zhang et al., 2009), which were not present after IT surgery.
However, similarly to RYGB, IT-operated animals exhibited
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Fig. 6. IT surgery increases the relative expression of Gammaproteobacteria in cecal contents. (A)Average phylum-level composition of cecal contents.
(B)Average class-level composition of cecal contents. (C)Average genus-level composition of cecal contents. *P<0.05 for IT compared with control and sham by
Student’s t-test; n10-14 per group.
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increases in Gammaproteobacteria and Escherichia (Furet et al.,
2010; Li et al., 2011; Zhang et al., 2009). Decreases in intestinal
enterobacteria (a member of the class Gammaproteobacteria) have
been shown to be associated with increases in intestinal bile acid
absorption (Miyata et al., 2011). Therefore, the increases in
intestinal Gammaproteobacteria observed after IT surgery do not
appear to be associated with the increases in circulating bile acid
concentrations. However, further study on the effect of other
members of this class on bile acid absorption is needed.
Increases in circulating bile acids might contribute the metabolic
improvements after IT surgery by signaling through TGR5 and
FXR. Increased circulating bile acids might contribute to increased
energy expenditure because cholic acid administration has been
shown to increase energy expenditure by signaling through TGR5
in brown adipose tissue and skeletal muscle (Watanabe et al., 2006).
Bile acid administration has also been shown to improve glucose
and lipid metabolism by potentiating GLP-1 secretion through
TGR5 signaling and by decreasing hepatic gluconeogenesis and
lipogenesis through FXR activation (Kalaany and Mangelsdorf,
2006; Pols et al., 2011; Thomas et al., 2009). However, gene
expression analysis revealed that indices of hepatic FXR activation
did not differ between groups. Furthermore, the decreased luminal
bile acid content in IT-operated animals in this study, as well as in
another previous study (Kohli et al., 2010), suggests that a
contribution of bile acids to the increase in nutrient-stimulated
GLP-1 secretion through direct stimulation of intestinal TGR5
receptors is unlikely.
A previous study reported that administration of TUDCA
decreased ER stress and improved insulin sensitivity in obese mice
(Ozcan et al., 2006). However, the effect of other bile acid sub-types
on ER stress is unknown. Thus, we hypothesized that the increase
in circulating bile acid concentrations after IT surgery might have
contributed to the improvements of insulin sensitivity and β-cell
mass by decreasing ER stress. All three sub-arms of ER stress
signaling were decreased in liver, adipose and pancreas of IT-
operated animals compared with controls. ER stress signaling was
decreased in skeletal muscle at 4.5 months, but not 1.5 months
after surgery. Notably, previous studies demonstrated that markers
of ER stress are activated in models of obesity in liver and adipose,
but not in skeletal muscle (Ozcan et al., 2004). Thus, attenuation
of ER stress is a likely contributor to the improvement of insulin
sensitivity in these tissues. Attenuation of ER stress in islets might
contribute to the preservation of β-cell mass and improvement of
insulin secretion in IT-operated animals. We found that β-cell mass
was significantly lower at 1.5 months and significantly higher at
4.5 months after surgery in IT-operated animals compared with
controls. We hypothesize that this was due to an improvement in
insulin sensitivity in IT-operated animals at 1.5 months after
surgery, resulting in less islet hypertrophy. At 4.5 months after
surgery, we hypothesize that IT-operated animals had become
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Fig. 7. IT surgery decreases markers of ER stress in liver, adipose, muscle and pancreas. (A)Representative immunoblots for pPERK(Thr980) and total PERK,
peIF-2α(Ser51) and total eIF-2α, pIRE1(Ser724) and total IRE1, sXBP1, BiP and tubulin in liver, skeletal muscle, mesenteric adipose and pancreas at 1.5 and 4.5
months after surgery. All blots were scanned and quantified using FluorChem 9900. (B-E)Results were quantified in densitromic units and expressed relative to
the total protein of interest or relative to tubulin for BiP, ATF6 and sXBP1 in liver (B), skeletal muscle (C), mesenteric adipose (D) and pancreas (E). *P<0.05,
**P<0.01, ***P<0.001 for IT compared with control and sham by Student’s t-test; n12 per group at 1.5 months and n16 per group at 4.5 months.
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relatively more insulin resistant, as reflected by the increase in
HOMA-IR at this time point, but were able to compensate for this
in part through an expansion of β-cell mass. Insulin signaling in
the β-cell has been shown to induce β-cell proliferation (Shawl et
al., 2009), and ER stress in the β-cell has been implicated in
progressive β-cell failure observed in type 2 diabetes (Harding and
Ron, 2002). However, because these measurements were made in
whole pancreas tissue, it is not possible to localize the decreases
of ER stress specifically to the islet component of the pancreas.
Nevertheless, preincubation of β-cells, hepatocytes and adipocytes
with cholic acid protected cells from the development of ER stress.
These results suggest that the increase in circulating cholic acid
concentrations in IT-operated animals might have contributed to
the reduction of ER stress in peripheral tissues. Further studies are
needed to test the effects of other bile acid subtypes that are
increased after IT surgery to protect against the development of
ER stress in insulin sensitive tissues.
It is important to note that the metabolic benefits of IT surgery
are likely not due to increases in circulating bile acid
concentrations alone. Increases in nutrient-stimulated GLP-1
secretion in the IT-operated rats also likely contributed to the
improvement of glucose homeostasis. GLP-1 has well known
effects to increase GSIS, decrease glucagon secretion and improve
insulin sensitivity (Baggio and Drucker, 2007; Brubaker and
Drucker, 2004). Improvement of GSIS was clearly demonstrated
during all 3 OGTTs in which IT-operated animals exhibited about
twofold greater GSIS compared with sham-operated and control
animals. IT-operated animals exhibited improved insulin
sensitivity compared with control and sham-operated animals
based on decreased HOMA-IR and increased activation of insulin
signaling in liver, skeletal muscle, mesenteric adipose and
pancreas. Increases in nutrient-stimulated GLP-1 secretion might
contribute to the improvement in insulin sensitivity by decreasing
lipotoxicity, which is considered an important contributor to
insulin resistance (Morino et al., 2006; Samuel et al., 2010). We
have previously reported that administration of a GLP-1 agonist
lowers circulating lipids in UCD-T2DM rats (Cummings et al.,
2010a). This effect is possibly mediated by increased fatty acid
oxidation (Sancho et al., 2006). IT-operated animals exhibited
clear reductions in lipotoxicity with lower fasting plasma lipids,
increased lipid clearance during the OFTT and decreased ectopic
lipid deposition.
dmm.biologists.org452
Metabolic benefits of IT surgeryRESEARCH ARTICLE
Fig. 8. Preincubation of hepatocytes, adipocytes and β-cells with cholate protects cells from the development of ER stress. Cells were incubated with 100
μM cholic acid or DMSO for 24 hours then exposed to 2 μM thapsigargin for 2 hours. (A)Representative immunoblots for pPERK(Thr980) and total PERK, peIF-
2α(Ser51) and total eIF2α, pIRE1(Ser724) and total IRE1, sXBP1, pJNK(Thr183/Tyr185) and total JNK and BiP. Experiments were performed in HepG2, differentiated
3T3 L1 adipocytes and β-TC6 cells. (B-D)Control cells (Con) were not exposed to cholic acid or thapsigargin. Other cells were exposed to chloic acid but not to
thapsigargin (CA), to thapsigargin but not cholic acid (Th), or preincubated with cholic acid and then exposed to thapsigargin (Th + CA). Results were quantified
in densitromic units and expressed relative to the total protein of interest or relative to tubulin for BiP, ATF6 and sXBP1 in hepatocytes (B), adipocytes (C) and β-
cells (D). *P<0.05, **P<0.01 for IT compared with Th by Student’s t-test. +P<0.05, ++P<0.01 compared with Con and CA by Student’s t-test; n3 per group.
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In conclusion, we have demonstrated that IT surgery in UCD-
T2DM rats delays diabetes onset with concurrent improvements
in glucose and lipid metabolism. Increases in GLP-1 probably
contribute to the improvements in glucose homeostasis; however,
the results from this study also indicate that increases in circulating
bile acid concentrations, particularly non-conjugated cholic acid,
might contribute to the improvement of insulin sensitivity and islet
function by decreasing ER stress. We have, for the first time,
demonstrated that both IT surgery and cholic acid decrease ER
stress in insulin-sensitive tissues, thus identifying a potential
pathway by which post-operative increases in circulating bile acid
concentrations might contribute to metabolic improvements
following bariatric surgery. Furthermore, these results emphasize
the importance of post-operative increases in circulating bile acids
in the beneficial metabolic effects of bariatric surgery and the
potential utility of targeting bile acid metabolism in the
management and prevention of type 2 diabetes.
MATERIALS AND METHODS
Diets and animals
Male UCD-T2DM rats were individually housed in hanging wire
cages in the animal facility in the Department of Nutrition at the
University of California, Davis and maintained on a 14:10 hour light-
dark cycle. Weight-matched animals were placed on study at 2
months of age and either underwent sham or IT surgery or were
placed in a non-operated control group. One subset of animals was
euthanized at 1.5 months after surgery (short-term study, n12)
and the rest were euthanized at 4.5 months after surgery (long-
term study, n16). Animals were euthanized with an overdose of
pentobarbital (200 mg/kg, i.p.) after an overnight fast. Tissues were
weighed and flash frozen in liquid nitrogen. Baseline and final
fasting blood samples were collected on the day of euthanasia. All
animals received ground chow (no. 5012, Ralston Purina, Belmont,
CA). Food intake and body weight were measured three times a
week. Non-fasting blood glucose was measured weekly with a
glucose meter (One-Touch Ultra, LifeScan, Milpitas, CA) at 14:00-
16:00 hours. Diabetes onset was defined as a non-fasted blood
glucose value >11.1 mmol/l on 2 consecutive weeks. Indirect
calorimetry was performed at 1.5 months after surgery using an
Accuscan Integra ME System. An OGTT was performed in all
animals at 1 month after surgery and then in long-term animals at
3 and 4 months after surgery (1g/kg body weight gavage with
dextrose). An OFTT was performed at 2 months after surgery
[1.5g/kg body weight gavage with Intralipid (Fresenius Kabi;
Uppsala, Swede)]. The experimental protocols were approved by
the UC Davis Institutional Animal Care and Use Committee.
IT surgery
IT surgery was performed as previously described (Cummings et
al., 2010c). Rats were placed on a liquid diet (Boost, Novartis,
Minneapolis, MN) 4 days prior to surgery and for 7 days post-
surgery and received enrofloxacin (20 mg/kg/d, s.c.) before and after
surgery. Anesthesia was induced and maintained with isoflurane
(1–5%). A midline abdominal incision was made and a 10-cm
segment of ileum 5-10 cm proximal to the ileocecal valve was
isolated and transected. An anastomosis was made with the
remaining ends of the ileum using 7-0 PDS suture (Ethicon). Next,
a transection was made 5-10 cm distal to the ligament of Treitz.
The isolated ileal segment was then inserted isoperistaltically.
Sham-operated animals were treated in the same manner as the
IT group. Sham surgeries were performed by making transections
in the same locations as in the IT-operated animals and bowel were
reattached by anastomosis in their original position.
Hormone and metabolite measurements
Fasting (13 hour) plasma and whole blood samples were collected
at baseline and on the day of euthanasia into EDTA-treated tubes.
Plasma was assayed for glucose, insulin, triglycerides, cholesterol,
adiponectin and glucagon. Plasma glucose, cholesterol and TG were
measured using enzymatic colorimetric assays (Thermo DMA
Louisville, CO). Adiponectin and PYY were measured using mouse-
or rat-specific radioimmunoassay (Millipore, St. Charles, MO).
Insulin and GIP were measured by ELISA (Millipore, St Charles,
MO). Total GLP-1 was measured by sandwich
electrochemiluminescence immunoassay (Meso Scale Discovery;
Gaithersburg, MA). HbA1c was measured using an enzymatic
colorimetric assay (Diazyme; Poway, CA).
Tissue triglyceride content measurement
Liver and skeletal muscle TG content were measured using the
Folch method for lipid extraction followed by spectrophotometric
measurement of TG content (Thermo Electron, Louisville, CO) as
previously described (Cummings et al., 2010b; Folch et al., 1957).
Islet immunohistochemistry
Whole pancreas samples were fixed in 4% paraformaldehyde. For
determination of β-cell mass, 8-10 sections per pancreas were
sectioned in a systematic uniform random manner and analyzed
as previously described (Paulsen et al., 2010). Immunostaining was
performed using a primary non--antibody dilution, including
mouse anti-glucagon, rabbit anti-somatostatin and rabbit anti-
pancreatic polypeptide and a secondary biotinylated antibody
mixture (Fab2 fragment donkey anti-mouse at 1:2000 dilution and
Fab2 fragment donkey anti-rabbit at 1:2000 dilution). Sections were
then blocked for 15 minutes in 10% rabbit normal serum
(Dakocytomation #X0902) and incubated overnight at 4°C in
guinea pig anti-insulin (Dakocytomation A0564). Sections were
eventually developed in NovaRed (Vector Laboratories, SK4800)
then stained in a Mayer solution. Stereological estimations were
performed on all sections using a Leica DMLB microscope (Leica,
Glostrup, Denmark). Systematic uniform random sampling within
a section was enabled by using an ECO-Drive microscope stage
(Märzhäuser Wetzlar, Wetzlar, Germany) controlled by a computer
with WIN-Commander 4.1.3.0 software (Märzhäuser). The applied
probes used for the stereological examinations (point-counting
grid) were fixed to the table so that the microscope projected the
image onto the grid. The pancreas area/volume and -mass/non-
-mass ratios were estimated with a 144-point grid. The total mass
of β-cells was calculated as:
where Mbeta is the total-cell mass, Pbeta is the total number of
points that hit -cells in all sections, Ppan the number of points
hitting pancreas, Pnon-pan the number of points hitting non-
pancreatic tissue and Mtis the wet weight of the removed tissue.
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Bile acids profiles
Fasting plasma bile acid profiles were analyzed at 2 months after
surgery, as previously described (Bootsma et al., 1999; Torchia et
al., 2001). An internal standard mixture of D4-cholate, D4-β-
muricholate, D4--muricholate, D4-chenodeoxycholate, D4-
deoxycholate, D4-hyodeoxycholate, D4-ursodeoxycholate and D4-
lithocholate and their tauroconjugated and glycoconjugated
counterparts was prepared in acetonitrile. Eluted bile salts were
detected by negative ion electrospray mass spectrometry on a linear
trap LTQ mass spectrometer (Thermo-Finnigan, San Jose, CA)
using a data-dependent stage of detection, triggering a qualitative
0 m/z neutral loss scan at 27% normalized collision energy. Peak
areas from initial scans of individual bile salts at 514.3, 498.3, 464.3,
447.3, 411.3, 407.3, 395.3, 393.3 and 391.3 m/z were integrated and
the response factors defined by peak area ratios of analytes to that
of internal, deuterated standards. The response factors were read
against those obtained from standard curves in surrogate matrix,
and molar levels of serum or plasma levels were interpolated from
standard curves. Response factors for all samples comprised peak
area ratios of non-labeled salts normalized to the stable-labeled
counterparts. Concentrations were interpolated by linear regression
from curves of known standards. Plasma and intestinal perfusates
were normalized to volume. Tissue bile salts were normalized to
tissue dry weight for calculations of total concentration. Percentages
were normalized to total mass of all bile salts detected.
rtPCR
RNA isolation from tissue and real-time PCR was performed
according to the manufacturer’s instructions using ABI Prism 6100
and ABI 7100 systems with assays on demand (Applied Biosystems,
Carlsbad, CA). Briefly, samples were lysed in 2× Nucleic Acid
Purification Lysis Solution (Applied Biosystems). Samples were
homogenized for 30 seconds and then treated with a proteinase K
solution and allowed to incubate for 1 hour under ambient
conditions. RNA was isolated on the ABI 6100 system and assessed
by agarose gel electrophoresis. Total RNA samples were diluted
(1:20), in RNase-free water. cDNA was generated using the ABI
High Capacity cDNA reverse transcription kit (Applied
Biosystems). Individual probes were obtained from ABI (Assays on
demand) for the genes ASBT, ARBP, CYP7A1, CYP8B1, FGF15,
IBABP, LRH-1, SHP, SL10A1, SLC10A2, SLC27A5 and SREPB1c.
These were mixed with diluted cDNA, cofactors and substrates and
processed on the ABI 7100 system. The signals were normalized
to that of the housekeeping gene ARBP.
Cecal microbiota
The cecal contents of animals euthanized at 4.5 months after
surgery were collected for analysis of microbial populations by
pyrosequencing performed by the Core for Applied Genomics and
Ecology (CAGE, University of Nebraska) using a Roche Genome
Sequencer GS-FLX. DNA was extracted using the QiaXtractor
(Qiagen, Valencia, CA). The V1-V2 region of the 16S rRNA gene
was amplified using bar-coded fusion primers with the Roche-454
A or B Titanium sequencing adapters. The PCR mixture contained
1 ml of forward primer mix, 1 ml of reverse primer, 0.25 ml of Ex-
Taq polymerase (TaKaRa Bio, Clontech Laboratories, Mountain
View, CA), 1.5 ml of the sample, 6.25 ml of Ex-Taq buffer, 5 ml of
deoxynucleotides and 37 ml of sterile distilled H2O. The PCR
program consisted of an initial denaturing step for 5 minutes at
95°C, followed by 30 cycles of denaturation at 95°C for 45 seconds,
annealing at 57°C for 45 seconds and extension at 72°C for 2
minutes, with a final step at 72°C for 10 minutes. The PCR
products were quantified on the basis of their staining intensity
using the image acquisition software Genesnap (Syngene USA).
PCR products were combined in equal amounts and gel-purified
using the QIAquick Gel Extraction Kit (Qiagen, USA).
Pyrosequencing was performed from the A end with the 454/Roche
A sequencing primer kit using a Roche Genome Sequencer GS-
FLX following the manufacturer’s protocol. Filter-pass reads were
parsed into sample-barcoded bins and uploaded to a publicly
accessible MySQL database (http://cage.unl.edu). Reads were
assigned taxonomic status with a parallelized version of the multi-
CLASSIFIER algorithm. Reads in each taxonomic bin were
normalized as the absolute proportion of the total number of reads
for each sample. Discriminant analysis was performed using a
multi-sample classifier downloaded from Ribosomal Database
Project (RDP; http://rdp.cme.msu.edu/).
Immunoblotting
Tissues were ground in liquid nitrogen and lysed using radio-
immunoprecipitation assay (RIPA) buffer (150 mM NaCl, 1.0%
IGEPAL CA-630, 0.5% sodium deoxycholate, 0.1% SDS, and 50 mM
Tris pH 7.4, 5 mM EDTA, 1 mM NaF, 1 mM sodium orthovanadate
and protease inhibitors). Lysates were clarified by centrifugation
at 10,000 r.p.m. (9600 g) for 10 minutes and protein concentrations
determined using a bicinchoninic acid protein assay kit (Pierce
Chemical, IL). Proteins were resolved by SDS-PAGE and transferred
to nitrocellulose membranes. Immunoblots were performed with
the indicated antibodies (supplementary material Table S4).
Proteins were visualized using enhanced chemiluminescence (ECL;
Amersham Biosciences) and the pixel intensities of immunoreactive
bands quantified using FluorChem 9900 (Alpha Innotech, CA).
Cell culture
HepG2 cells were maintained in culture in a humidified 5% CO2
atmosphere at 37°C in complete medium consisting of regular
Delbecco’s modified Eagle’s medium (DMEM) supplemented with
10% fetal bovine serum (FBS), 100 units/ml penicillin and 100 μg/ml
streptomycin. 3T3-L1 cells were maintained in high glucose (25
mM) DMEM supplemented with 10% newborn calf serum and
penicillin-streptomycin. When confluent (designated day 0), cells
were switched to high insulin (1.7 μM), high glucose DMEM
supplemented 10% FBS. Differentiation of 3T3-L1 pre-adipocytes
was induced at day 2 by switching to high insulin, high glucose
DMEM supplemented with 10% FBS, 1 μM dexamethasone, and
0.5 mM 3-isobutyl-l-methylxanthine. After 48 hours, the medium
was switched back to high insulin, high glucose DMEM
supplemented 10% FBS. -TC6 insulinoma cells (ATCC: CRL-
11506) were cultured in DMEM containing 25 mM glucose, 15%
FBS, 50 U/ml penicillin and 50 μg/ml streptomycin and maintained
in a CO2 incubator (8% CO2) at 37°C. ER stress was induced in
cells by treatment with thapsigargin (2 μM) for 2 hours.
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Statistics and data analyses
All statistical analyses were performed using GraphPad Prism 4.00
for Windows (GraphPad Software, San Diego, CA). Data were
analyzed by two-factor repeated measures ANOVA with
Bonferroni’s post-test or Student’s t-test where appropriate.
Differences were considered significant at P<0.05. Data are
expressed as mean ± s.e.m.
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Fig. S1. IT surgery decreases inflammation at 4.5 months after surgery. (A) Representative immunoblots for TNF-a, MCP-1 
and tublin in liver, adipose and muscle at 1.5 and 4.5 months after surgery. (B-D) Results were quantified in densitromic units and 
expressed relative to tublin in liver (B), skeletal muscle (C) and mesenteric adipose (D). *P<0.05, **P<0.01, ***P<0.001 compared 
with control and sham by Student’s t-test; n=12 per group at 1.5 months and n=16 per group at 4.5 months. Data are expressed as 
mean±s.e.m.
Table S1. Plasma hormones, metabolites and tissue TG content
Control Sham IT
Short Term Study Baseline 1.5 mo Baseline 1.5 mo Baseline 1.5 mo
Fasting plasma glucose (mmol/L) 5.2 ± 0.1 6.3 ± 0.1+++ 5.5 ± 0.1 6.3 ± 0.1+++ 5.4 ± 0.1 5.7 ± 0.1**
HbA1c (%) 4.1 ± 0.1 4.4 ± 0.2 4.3 ± 0.1 4.5 ± 0.2 4.1 ± 0.1 4.3 ± 0.2**
Fasting plasma insulin (pmol/L) 191 ± 28 526 ± 49+++ 168 ± 22 519 ± 34+++ 165 ± 20 280 ±20+++,***
HOMA-IR (A.U.) 6.5 ± 1.1 21.0 ±1.9+++ 6.1 ± 0.9
20.9 ±
1.6+++ 5.7 ± 0.7
10.3 ±
0.8+++, ***
Fasting plasma TG (mmol/L) 0.8 ± 0.1 1.7 ± 0.1+++ 0.8 ± 0.1 1.5 ± 0.1+++ 0.8 ± 0.1 1.2 ±0.1+++,*
Fasting plasma cholesterol (mmol/L) 2.3 ± 0.1 2.6 ± 0.1++ 2.5 ± 0.1 2.9 ± 0.1++ 2.5 ± 0.1 2.6 ± 0.1+
Fasting plasma adiponectin (pmol/L) 137 ± 14 198 ± 12++ 150 ± 15 189 ± 22 167 ± 13 209 ± 7++
Fasting plasma total GLP-1 (pmol/L) 1.0 ± 0.3 2.1 ± 0.5 1.3 ± 0.3 1.5 ± 0.4 1.2 ± 0.2 4.0 ±0.6+++,*
Liver TG (mg/g liver) ND 20.9 ± 2.5 ND 17.2 ± 1.7 ND 13.6 ± 1.1*
Skeletal muscle TG (mg/g muscle) ND 3.0 ± 0.3 ND 3.2 ± 0.4 ND 2.0 ± 0.1**
Long Term Study Baseline 4.5 mo Baseline 4.5 mo Baseline 4.5 mo
Fasting plasma glucose (mmol/L) 5.1 ± 0.1 7.5 ± 2.9++ 5.1 ± 0.1 8.3 ± 1.0++ 5.1 ± 0.1 6.0 ±0.1+++,*
HbA1c (%) 4.0 ± 0.1 7.0 ± 0.7+++ 4.0 ± 0.2 7.9 ± 0.8+++ 4.0 ± 0.1 5.9 ± 0.4+++
Fasting plasma insulin (pmol/L) 189 ± 35 387 ± 47++ 158 ± 19 412 ± 48+++ 145 ± 14 411 ± 33+++
HOMA-IR (A.U.) 6.3 ± 1.2 20.4 ±2.2+++ 5.3 ± 0.7
18.5 ±
1.3+++ 4.7 ± 0.5
15.4 ±
1.3+++, *
Fasting plasma TG (mmol/L) 0.8 ± 0.1 1.4 ± 0.1+++ 0.9 ± 0.1 1.4 ± 0.1+++ 0.8 ± 0.1 1.4 ± 0.1+++
Fasting plasma cholesterol (mmol/L) 2.3 ± 0.1 3.2 ± 0.1+++ 2.4 ± 0.1 3.3 ± 0.1+++ 2.3 ± 0.1 3.0 ± 0.1+++
Fasting plasma adiponectin (pmol/L) 167 ± 13 183 ± 12 173 ± 11 169 ± 11 180 ± 7 179 ± 13
Fasting plasma total GLP-1 (pmol/L) 2.0 ± 0.3 4.3 ± 0.5+++ 2.2 ± 0.3 3.0 ± 0.5 2.3 ± 0.3 4.3 ±0.5+++,+
Liver TG (mg/g liver) ND 17.7 ± 2.5 ND 14.5 ± 1.5 ND 17.3 ± 1.4
Skeletal muscle TG (mg/g muscle) ND 3.5 ± 0.3 ND 3.2 ± 0.2 ND 3.3 ± 0.1
+P<0.05 compared with sham, *P<0.05, **P<0.01, ***P<0.001 compared with control and sham by two-factor
repeated measures ANOVA with Bonferroni’s post-test, ++P<0.01, +++P<0.001 compared to baseline by
Student's t-test. n=12 per group at 1.5 months, n=16 per group at 4.5 months. Data are expressed as mean ±
SEM.
Table S2. Percent change in insulin from fasting to peak values during the OGTTs
1 month OGTT
% Change
3 months OGTT
% Change
4 months OGTT
% Change
Control 74 ± 11 80 ± 16 62 ± 20
Sham 86 ±13 68 ± 13 65 ± 12
IT 192 ± 24*** 129 ± 17** 100 ± 16*
*P<0.05, **P<0.01, ***P<0.001 compared with control and sham by two-factor repeated measures ANOVA
with Bonferroni’s post-test. n=28 per group during the 1 month OGTT, n=16 per group during the 3 and 4
month OGTTs. Data are expressed as mean ± SEM.
Table S3. Tissue weights
Short Term Study Control Sham IT
Epididymal fat pads (g) 6.7 ± 0.3 6.0 ± 0.5 4.7 ± 0.3*
Retroperitoneal fat pads (g) 10.2 ± 0.9 9.4 ± 0.8 6.8 ± 0.7*
Subcutaneous fat (g) 34.9 ± 1.9 34.0 ± 5.4 25.9 ± 1.5**
Mesenteric fat (g) 6.0 ± 0.5 7.5 ± 0.7 6.1 ± 0.5
Total white adipose tissue (g) 57.8 ± 3.4 56.9 ± 3.2 43.5 ± 2.8**
Heart (g) 1.4 ± 0.03 1.4 ± 0.03 1.4 ± 0.03
Kidney (g) 1.7 ± 0.03 1.7 ± 0.04 1.7 ± 0.04
Liver (g) 17.2 ± 0.4 17.4 ± 0.4 16.0 ± 0.4*
Long Term Study Control Sham IT
Epididymal fat pads (g) 8.0 ± 0.8 9.2 ± 0.5 9.7 ± 0.6
Retroperitoneal fat pads (g) 11.0 ± 0.9 12.2 ± 0.6 12.9 ± 0.7
Subcutaneous fat (g) 42.2 ± 4.3 43.2 ± 2.6 45.9 ± 2.2
Mesenteric fat (g) 6.8 ± 0.8 8.4 ± 0.6 11.3 ± 0.6*
Total white adipose tissue (g) 68.1 ± 6.5 73.0 ± 4.1 79.9 ± 3.9
Heart (g) 1.5 ± 0.04 1.5 ± 0.03 1.5 ± 0.02
Kidney (g) 2.0 ± 0.05 2.0 ± 0.04 1.9 ± 0.04
Liver (g) 19.6 ± 6.5 20.1 ± 0.4 20.5 ± 0.5
Values are mean ± SEM. n=12 per group at 1.5 months, n=16 per group at 4.5 months *P<0.05, **P<0.01,
***P<0.001 compared to control and sham by Student's t-test.
Table S4. Western blot antibodies
Antibody Source Host Dilution for WB
IRE Abcam Rabbit 1:1000
ATF6 Abcam Mouse 1:1000
BiP Santa-Cruz Rabbit 1:2000
eIF2_ Santa-Cruz Mouse 1:1000
Akt Santa-Cruz Mouse 1:50000
JNK Santa-Cruz Mouse 1:10000
MAPK Cell Signaling Rabbit 1:50000
MCP-1 Biovision Rabbit 1:1000
PERK Santa-Cruz Rabbit 1:1000
sXBP1 Santa-Cruz Rabbit 1:1000
TNF-_ Santa-Cruz Goat 1:1000
pPERK (Thr980) Cell Signaling Rabbit 1:1000
pAkt (Ser473) Cell Signaling Rabbit 1:100000
peIF2_ (Ser51) Santa-Cruz Rabbit 1:10000
pJNK(Thr183/Tyr185) Santa-Cruz Mouse 1:10000
pMAPK(Thr202/Tyr204) Cell Signaling Rabbit 1:100000
pIRE (Ser724) Abcam Rabbit 1:1000
CD31 Santa-Cruz Mouse 1:1000
VEGF Santa-Cruz Rabbit 1:1000
Tublin Santa-Cruz Mouse 1:100000
